| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/15/2009 | EP2077829A2 Pai-1 binding modulators for the treatment of ocular disorders |
| 07/15/2009 | EP2005954A9 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | EP1328263B1 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513565C Apoptin-associating protein |
| 07/15/2009 | CN100513404C Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/15/2009 | CN100512842C Disinfectant |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/15/2009 | CN100512805C Sesquiterpene injection, preparing method and use thereof |
| 07/15/2009 | CN100512803C Natural carotene soft capsule and its production method |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 07/14/2009 | US7560551 Aurora kinase modulators and method of use |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560543 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
| 07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560435 Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine) |
| 07/14/2009 | US7560253 Detecting level of expression of a hemopoietic linkage switch-5 (HLS-5) polynucleotide in a biological sample from a suspected or known cancer patient |
| 07/14/2009 | US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | CA2543665C Cci-779 for treating mantle cell lymphoma |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2366754C Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 07/14/2009 | CA2242542C Compositions and methods for therapeutic use |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086516A1 Anti-proliferative compounds and their use |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086324A1 Anti-hedgehog antibodies |
| 07/09/2009 | WO2009086264A1 Benzofuropyrimidinones as protein kinase inhibitors |
| 07/09/2009 | WO2009086204A2 Methods for treating neuropsychiatric conditions |
| 07/09/2009 | WO2009086201A1 2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents |
| 07/09/2009 | WO2009086192A1 Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents |
| 07/09/2009 | WO2009086108A1 Stable elsamitrucin salt formulations |
| 07/09/2009 | WO2009085983A1 5-anilinoimidazopyridines and methods of use |
| 07/09/2009 | WO2009085980A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 07/09/2009 | WO2009085920A1 Fdf03 antibodies and uses thereof |
| 07/09/2009 | WO2009085913A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
| 07/09/2009 | WO2009085262A1 Method of treating cancer with immunomodulatory compounds and igg |
| 07/09/2009 | WO2009085230A1 Inhibitors of pi3 kinase |
| 07/09/2009 | WO2009085209A2 Methods for using and identifying modulators of delta-like 4 |
| 07/09/2009 | WO2009085185A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 07/09/2009 | WO2009084982A1 Use of organic dyes as an agent for treating oncological diseases |
| 07/09/2009 | WO2009084739A1 Method and pharmaceutical composition for treatment of cancer using bmp10 protein, |
| 07/09/2009 | WO2009084738A1 Method and pharmaceutical composition for treatment of cancer using bmp9 protein |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084693A1 Antitumor agent |
| 07/09/2009 | WO2009084680A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084216A1 Oral powder and granular antitumor agent |
| 07/09/2009 | WO2009083755A1 Use of t cells expressing cd16 receptors for enhancing the antibody-dependent cellular cytotoxiciy (adcc) |
| 07/09/2009 | WO2009083738A2 Rna delivery vehicles |
| 07/09/2009 | WO2009083614A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | WO2009083232A1 Parvovirus cancer therapy and combination with chemotherapy |
| 07/09/2009 | WO2009083076A1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 07/09/2009 | WO2009083042A1 Methods and means for the treatment of cancer |
| 07/09/2009 | WO2009083009A2 Monoclonal antibodies against cd32b |
| 07/09/2009 | WO2009082817A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | WO2009066955A3 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same |
| 07/09/2009 | WO2009057795A3 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009037705A3 Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2009020933A9 Therapeutic use of anti-tweak receptor antibodies |
| 07/09/2009 | WO2009012096A3 Improved therapeutic methods and compositions comprising chroman ring compounds |
| 07/09/2009 | WO2008151833A3 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds |
| 07/09/2009 | WO2008147864A3 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | WO2008136976A3 Compounds for treating proliferative disorders |
| 07/09/2009 | WO2008090355A3 Inhibitors of stem cells markers |
| 07/09/2009 | WO2008054431A3 Anti-hyperproliferative therapies targeting hdgf |
| 07/09/2009 | WO2008040190A8 Small peptides for anti-angiogenesis and use thereof |
| 07/09/2009 | WO2007098548A8 A molecule and chimeric molecules thereof |
| 07/09/2009 | US20090178148 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |